ArticleDiabetes care2020
Diabetes Epidemiology in the COVID-19 Pandemic.
Article in Diabetes care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.
- Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis.Diabetes care · 2021Pooled it
- Vitamin E fails to prevent bisphenol S induced testicular damage in diabetic rats.Scientific reports · 2026Article
- Review
- Psychosocial and behavioral risk patterns and risk of cardiovascular complications in people with type 2 diabetes.Diabetes research and clinical practice · 2025Article
- The positive implication of natural antioxidants on oxidative stress-mediated diabetes mellitus complications.Journal, genetic engineering & biotechnology · 2024Review
- [Metabolic alterations observed in patients undergoing endocrinological follow-up during the first year of confinement due to Covid-19]Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2024Observational
- The Antidiabetic Potential of Probiotics: A Review.Nutrients · 2024Review
- Perception and coping mechanisms of patients with diabetes mellitus during the COVID-19 pandemic in Ibadan, Nigeria.PloS one · 2024Article
- Prediction of in-hospital mortality rate in COVID-19 patients with diabetes mellitus using machine learning methods.Journal of diabetes and metabolic disorders · 2023Article
- Association Between Diabetes Severity and Risks of COVID-19 Infection and Outcomes.Journal of general internal medicine · 2023Article
- A multicenter international prospective study of the validity and reliability of a COVID-19-specific health-related quality of life questionnaire.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023Article
- Exploring disparities and novel insights into metabolic and cardiovascular comorbidities among COVID-19 patients in Mexico.Frontiers in public health · 2023Observational
- Developing a nomogram for predicting depression in diabetic patients after COVID-19 using machine learning.Frontiers in public health · 2023Article
- Article
- Highly perturbed genes and hub genes associated with type 2 diabetes in different tissues of adult humans: a bioinformatics analytic workflow.Functional & integrative genomics · 2022Article
- COVID-19 associated diabetes mellitus: A review.World journal of diabetes · 2022Review
- Urban-Rural Differences in Health Care Utilization and COVID-19 Outcomes in Patients With Type 2 Diabetes.Preventing chronic disease · 2022Article
- Moderately hyperglycemia as an independent prognostic factor for the worse outcome of COVID-19.Primary care diabetes · 2022Article
- Lower handgrip strength levels probably precede triglyceride glucose index and associated with diabetes in men not in women.Journal of diabetes investigation · 2022Article
- Factors Influencing the Utilization of Diabetes Complication Tests Under the COVID-19 Pandemic: Machine Learning Approach.Frontiers in endocrinology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comorbidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.